Clinical Trials Logo

Filter by:
NCT ID: NCT03199235 Completed - Anemia Clinical Trials

Iron Fish in Dominican Republic (DR) Children

Start date: February 20, 2017
Phase: N/A
Study type: Interventional

The objective of the study is to assess the acceptability, feasibility, and barriers to Lucky Iron Fishâ„¢ (LIF) utilization among families with young children in a Latin American community with a high prevalence of iron deficiency and iron-deficiency anemia.

NCT ID: NCT03154125 Completed - Contraception Clinical Trials

Sayana® Press Extension Study

Start date: September 22, 2017
Phase: Phase 3
Study type: Interventional

This is a randomized clinical trial designed to evaluate the effectiveness, safety and acceptability of Sayana® Press when injected every 4 months (17-18 weeks) for 3 treatment cycles (12 months) of use.

NCT ID: NCT03107611 Completed - Atopic Dermatitis Clinical Trials

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

Start date: February 29, 2016
Phase: Phase 3
Study type: Interventional

To establish the bioequivalence between test drug, Pimecrolimus Cream, 1% with that of reference listed drug, Elidel® (pimecrolimus) Cream 1%, in the treatment of mild to moderate Atopic Dermatitis. To establish superiority of each active treatment over the placebo.

NCT ID: NCT03021499 Completed - Lupus Nephritis Clinical Trials

Aurinia Renal Response in Active Lupus With Voclosporin

AURORA
Start date: May 17, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.

NCT ID: NCT03005964 Completed - Plaque Psoriasis Clinical Trials

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

Start date: December 2016
Phase: Phase 2
Study type: Interventional

To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of plaque psoriasis

NCT ID: NCT02943070 Completed - Clinical trials for Benign Prostatic Hyperplasia

Rezum I Pilot Study for Benign Prostatic Hyperplasia

Rezum Pilot
Start date: March 2012
Phase: N/A
Study type: Interventional

Evaluate the safety and efficacy of the Rezum System for the treatment of BPH

NCT ID: NCT02940392 Completed - Clinical trials for Benign Prostatic Hyperplasia

Rezum FIM Optimization Study

Rezum FIM
Start date: March 19, 2012
Phase: N/A
Study type: Interventional

Evaluate the effect of the NxThera BPH Rezum System on prostate tissue in subjects suffering from LUTS symptoms secondary to benign prostatic hyperplasia (BPH).

NCT ID: NCT02904369 Completed - HIV Clinical Trials

PK and PD Study of Oral F/TAF for HIV Prevention

Start date: October 6, 2016
Phase: Phase 1
Study type: Interventional

This multi-center Phase I study is designed to characterize the PK and PD of F/TAF oral tablets to assess systemic and genital tract bioavailability in healthy women. The oral tablets to be used in the study are F/TAF (200/10 mg), F/TAF (200/25 mg) and F/TDF (200/300 mg, Truvada). Samples will be obtained before, during and after dosing in two study phases.

NCT ID: NCT02860052 Completed - Tinea Pedis Clinical Trials

SB208 for the Treatment of Tinea Pedis

Start date: July 19, 2016
Phase: Phase 2
Study type: Interventional

This is a phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted in non immunocompromised adult subjects with interdigital tinea pedis.

NCT ID: NCT02815280 Completed - Acne Vulgaris Clinical Trials

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Start date: May 2016
Phase: Phase 3
Study type: Interventional

This is a Phase 3 study to evaluate the efficacy, safety and long-term safety of the topical administration of FMX-101, 4% minocycline foam for the treatment of moderate-to-severe acne vulgaris.